Home > Insider Trading > Filing (0001348324-15-000034)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1348324	Ldr Holding Corp	LDRH	Surgical & Medical Instruments & Apparatus (3841)	203933262

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1586612	Joseph G. Ross	13785 Research Blvd., Suite 200 Austin TX 78750	Exec Vp Global Marketing	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-03-05	22,222	$3.11	23,681	No	4	M	Direct
Common Stock	Acquisiton	2015-03-05	7,695	$3.11	31,376	No	4	M	Direct
Common Stock	Disposition	2015-03-05	31,376	$37.91	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Incentive Stock Option (right to buy)	Disposition	2015-03-05	22,222	$0.00	22,222	$3.11
Common Stock	Incentive Stock Option (right to buy)	Disposition	2015-03-05	7,695	$0.00	7,695	$3.11

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2011-12-01	2020-11-19	No	4	M	Direct
2,288	2012-02-01	2020-11-19	No	4	M	Direct

Footnotes

Includes 196 ESPP shares acquired under the LDR Holding Corporation Amended and Restated 2013 Employee Stock Purchase Plan on May 30, 2014. Also includes 1,263 shares acquired through an RSU grant which vested on January 16, 2015.
The price indicated is the weighted average sale price for the shares sold. The individual sale prices for the shares indicated range from $37.30 to $38.34. The reporting person undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, further information regarding the number of shares sold at each separate price such shares were sold.
The option becomes exercisable for 25% of the shares granted one year from the vesting commencement date of December 1, 2010, then in thirty-six equal monthly installments thereafter.
ISO becomes exercisable in combination with NQSO granted on the same date wherein the shares vest in forty-eight equal monthly installments from the vesting commencement date of January 1, 2012.